Yervoy may face Roche rival sooner than expected
Yervoy may face Roche rival sooner than expected Fierce Pharma
View ArticleBiotech Calendar: 2011-12 FDA Drug Approvals
Biotech Calendar: 2011-12 FDA Drug Approvals TheStreet.com
View ArticleRoche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma Q
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma Bloomberg
View ArticleHungry biotechs make better partners for Big Pharma
Hungry biotechs make better partners for Big Pharma Fierce Biotech
View ArticleRoche melanoma drug wins European green light
Roche melanoma drug wins European green light Reuters
View ArticleYear in Review: Melanoma Drug Still on a Roll
Year in Review: Melanoma Drug Still on a Roll Med Page Today
View ArticleRoche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says
Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says Bloomberg
View ArticleNew Zelboraf data shows big survival boost
New Zelboraf data shows big survival boost Fierce Pharma
View ArticleRoche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing
Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing Bloomberg
View ArticleYervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share Seeking Alpha
View ArticleRoche’s Skin Cancer Treatment Delayed By U.K. Drug-Cost Agency
Roche’s Skin Cancer Treatment Delayed By U.K. Drug-Cost Agency Bloomberg
View ArticleReport: Roche's Zelboraf, BMS' Yervoy control their segment
Report: Roche's Zelboraf, BMS' Yervoy control their segment Fierce Pharma
View ArticleGenentech takes Exelixis drug into Phase III melanoma trial
Genentech takes Exelixis drug into Phase III melanoma trial Bizjournals.com
View ArticleYervoy-Zelboraf combo trial stopped on toxicity worries
Yervoy-Zelboraf combo trial stopped on toxicity worries Fierce Pharma
View ArticleLargest cancer gene database made public
Largest cancer gene database made public Reuters
View ArticlePfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy Seeking Alpha
View Article
